title: A sweet surprise for HIV broadly neutralizing antibodies.
abstract: The production of cross-reactive neutralizing antibodies is the ultimate goal in HIV vaccine development, but no immunogen other than HIV itself has been able to elicit this type of humoral immunity. In natural HIV infections, these antibodies take several years to develop. A new study sheds light on what may be causing this delay in neutralizing antibody development (pages 1688-1692).
authors.affiliation: Crucell Holland BV, Leiden, The Netherlands. hlangedi@its.jnj.com
authors.forename: Johannes P M
authors.initials: JP
authors.lastname: Langedijk
authors.forename: Hanneke
authors.initials: H
authors.lastname: Schuitemaker
mesh_terms: D057134:Antibodies, Neutralizing; D000939:Epitopes; D005260:Female; D006678:HIV; D015497:HIV-1; D006801:Humans; D011134:Polysaccharides
chemical_list: D057134:Antibodies, Neutralizing; D000939:Epitopes; D011134:Polysaccharides